Introduction
Transfusion of red blood cells (RBC) in patients undergoing coronary artery bypass grafting (CABG) is associated with increased mortality and morbidity w1-4x. Transfusion of RBC as a risk factor for early mortality has been well established whereas the effect of RBC transfusion on late mortality has been less well described.
This study analyzes the effect of perioperative transfusion of RBC on short-and long-term mortality after CABG in our centre and compares survival rates with expected survival based on the general Dutch population.
Methods
The study was performed after permission of the local Medical Ethics Committee. We studied the data of all patients undergoing isolated CABG in our center between January 1998 and December 2007. Clinical data were prospectively collected in our database. Patients were classified into four groups stratified by number of units of transfused RBC: group 1 did not receive any unit of RBC; *Corresponding author. Tel.: q31 40 239 86 80; fax: q31 40 244 02 68. E-mail address: aasmsn@cze.nl (M.A. Soliman Hamad). ns6828 (65.5%), group 2 received 1-2 units; ns2371 (22.7%), group 3 received 3-5 units; ns900 (8.6%) and group 4 received 6-10 units; ns326 (3.1%). Patients with )10 units of transfused RBC were excluded from further analyses (ns69).
Normothermic extra-corporeal circulation (ECC) was performed using non-pulsatile flow. Cold crystalloid cardioplegia ('St Thomas' solution) or warm blood cardioplegia was used to induce and maintain cardioplegic arrest, according to the surgeon's preference. All patients undergoing CABG with the use of ECC, received a low dose aprotinin (2 million kallikrein inactivating units) during ECC.
Follow-up data concerning mortality of patients were gathered using databases of health insurance companies, general practitioners and local authorities. Early mortality was defined as any cause mortality F30 days postoperatively, while late mortality was defined as any cause mortality )30 days.
To calculate the survival rate of general population cohorts that were matched for age and gender with patient groups, data were used from the database of the Dutch Central Bureau for Statistics (CBS). We considered the survival of the matched population cohort the expected survival of the patient group. Data are expressed as number (percentage). CVA, cerebrovascular accident; IABP, intra-aortic balloon pump support; Periop MI, perioperative myocardial infarction; RBC, red blood cells.
Statistical analyses
Discrete variables were compared with the x -test and 2 are presented as numbers and percentages. Continuous variables were compared with the Student t-test and analysis of variance (ANOVA). Univariate and multivariate logistic and Cox proportional hazard regression analyses were performed to investigate the impact of perioperative transfusion of blood products on early and late mortality at follow-up. Univariate analyses were used to test for the potentially confounding effect of biomedical and demographic factors on outcome. The cumulative long-term survival was estimated according to the Kaplan-Meier method, comparing differences between groups with the log-rank test. One-, five-and ten-year survival were compared using the time table method and the Wilcoxon test. A P-0.05 was used for all tests to indicate statistical significance. All statistical analyses were performed using SPPS version 15.0 (SPSS Inc, Chicago, IL).
Results
During a ten-year period (January 1998 until December 2007) 10,626 patients underwent CABG. After excluding patients who were lost to follow-up (ns122) and patients who received )10 units of RBC (ns80), 10,425 patients were analyzed. The total number of transfused units of RBC was 10,006; the total number of transfused units of fresh frozen plasma (FFP) was 2095; and the total number of transfused units of platelets was 375. The minimum follow-up period for surviving patients was 60 days. Mean follow-up was 1691"1058 days wrange: 0 (operative death)-3708 daysx. Median was 1629 days.
Baseline characteristics stratified by the number of received units of RBC are shown in Table 1 .
Patients in group 1 were more often younger males, had less often chronic obstructive pulmonary disease (COPD) and peripheral vascular disease (PVD), had a better left ventricular function wejection fraction (EF) )35%x, renal function and a higher preoperative hemoglobin level and a shorter duration of ECC (ECC-time). Emergency operations and previous cardiac surgery were seen more frequently in groups 3 and 4. Patients receiving more RBC received also more FFP and platelets.
The incidence of postoperative complications stratified by the number of received units of RBC is shown in Table 2 .
Univariate logistic regression analyses revealed the numbers of units of RBC, FFP and platelets as continuous variables as risk factors for early mortality ( Table 3 ).
All risk factors that were identified with univariate logistic regression analyses were entered into a multivariate logistic regression model. The number of units of RBC as a continuous variable was an independent risk factor for early mortality.
Results of Cox regression analyses regarding risk factors of late mortality are shown in Table 4 . Univariate analyses revealed the numbers of units of transfused RBC, FFP and platelets as risk factors for late mortality.
All risk factors that were identified with univariate analyses were entered into the multivariate Cox regression model. The number of units of transfused RBC, FFP and platelets were not identified as predictors of late mortality. In Figs. 1 and 2 , the long-term and expected survival of the patients receiving 0 or 1-2 RBC and patients receiving 3-5 or 6-10 RBC is shown. Fig. 3 shows the correlation between the number of transfused RBC units and the predicted mortality.
Log-rank test showed significant differences between all patient groups. One, five and nine years survival rates are shown in Table 5 . Patients receiving 0 RBC had a better than expected five and nine years survival. No difference was found between the one, five and nine years survival Nine years because of small numbers at ten years. Results as percentage cumulative survival"S.E. at the time of the interval.
rates of patients receiving 1-2 RBC and their expected survival rates, whereas one, five and nine years survival rates of patients receiving )2 RBC were worse than expected.
Discussion
This study revealed the number of transfused RBC to be an independent predictor of early but not for late mortality after CABG. Compared to expected survival, we noted that in patients receiving three or more units of RBC survival was decreased significantly, whereas receiving no RBC improved patient survival.
Blood products are transfused to increase hemoglobin and thereby improving tissue oxygenation and finally outcome w1, 3, 5-8x. However, several studies suggest that transfusion of blood products may be harmful by increasing the risk of postoperative infection, myocardial or cerebrovascular ischemia, renal failure, poorer functional recovery and death w1-5, 7, 8x. Transfusion of blood products may initiate a second inflammatory response by modification of the patient's systemic response and by directly introducing bioactive substances into the circulation, apart from the primary inflammatory response initiated by cardiopulmonary bypass w2-4, 6, 8, 9x. Our study has shown that patients who received G3 RBC units had a higher incidence of postoperative complications. This can explain the higher early mortality in these patients.
According to Koch and colleagues w2x, patients who received blood products had a significantly reduced postoperative functional recovery at six months. Kuduvalli et al. as well as Murphy et al. described a higher mortality rate in the first 30 days after operation as well as through the first postoperative year in patients who received perioperative blood transfusions w3, 6x. Engoren et al. found transfusion to be a risk factor for long-term (up to five years) mortality w7x. Koch et al. showed a significantly reduced survival of transfused patients at six months, five and ten years w4x. Our findings of reduced long-term survival in patients receiving peri-operative RBC transfusions are in agreement with these investigations, though in our study the number of RBC transfusions was not identified as an independent predictor of late mortality. Therefore, reduced long-term survival in patients receiving )2 units of RBC might be explained by higher early mortality.
The incidence of re-exploration (in most cases for excessive bleeding) is much higher in patients receiving more RBC. We tried to compensate for this possible confounding effect by entering re-exploration into the multivariate model together with the number of RBC. The threshold of the hemoglobin level for transfusion of RBC in our center is 9 gydl unless postoperative ischemia is present. The threshold increases to 11 gydl in case of ischemia. This explains why the incidence of peri-operative myocardial infarction (MI) is higher in patients receiving more RBC. In the present study, peri-operative MI was an independent predictor of early as well as late mortality. After adjustment for excessive bleeding and postoperative ischemia, the number of transfused RBC is still an independent predictor of early mortality.
With regard to other baseline characteristics, the patient groups also appeared to be widely different. Well-known risk factors for early as well as late mortality such as older age, COPD, diabetes, low CrCl, EF-35%, and others were more frequently found in patients receiving more RBC transfusions. These findings are in agreement with the findings of previous reports w2, 4, 5, 7, 8, 10x . When adjusted for these risk factors by multivariate analyses, transfusion of RBC was an independent risk factor for early mortality after CABG. In order to eliminate the confounding effect of exceptional surgical problems we excluded patients who received )10 units of RBC. Such a massive transfusion was mostly caused by massive blood loss or other special circumstances which certainly affect the prognosis.
In our study, the number off-pump coronary artery bypass (OPCAB) operations is relatively small (8.9%). Although OPCAB was not identified as a significant factor for early or late mortality, the number of patients having OPCAB was significantly higher in patients receiving no transfusion than in the other groups. This means that OPCAB can decrease the need for RBC transfusions, which confirms the conclusions of other investigators w11x. We used the Dutch CBS database to calculate the survival of the general population cohorts. This organisation keeps track of mortality rates of the overall Dutch population.
Late survival is highly dependent on age. Because age is significantly different between the patient groups we found it necessary to match for age when comparing long-term survival after CABG to the long-term survival of a matched general population cohort.
Female gender is considered an independent risk factor for early mortality after CABG w12-14x. In this study, we could not confirm this finding. Multivariate analysis, however, designates male gender as risk factor for late mortality. Abramov et al. concluded the same after adjustment for other risk factors w12x. Therefore, we decided to match the general population cohorts for sex.
In patients who did not receive any blood products we observed a better than expected survival. However, these results must be interpreted with care. Before undergoing CABG, patients are screened for severe underlying diseases. If severe underlying disease is present, it is aggressively treated or alternative treatment to CABG is considered, thus, biasing the CABG group. Survival of patients who received 1-2 units of blood products was not significantly different from the expected survival rate.
In patients who received )2 units of blood products a worse than expected survival was noted. When studying the survival curves and life table, it is obvious that after the early postoperative period the curves run parallel. This finding confirms our observation that the number of transfused RBC was not a predictor of late mortality. It might be reassuring for patients to know that if they survive the first postoperative period, their prognosis is not influenced anymore by the blood transfusions they received.
Limitations
This is an observational retrospective investigation, in which unknown variables could influence final results. Furthermore, we did not study the effect of duration of RBC storage. This issue has been recently addressed w15x. The strengths of this investigation are the large prospectively collected data set and the follow-up period of ten years.
Conclusion
Peri-operative transfusion of RBC is an independent, dosedependent risk factor for early but not for late mortality after CABG. Compared to expected survival, receiving no RBC improves patient's long-term survival, whereas receiving three or more units of RBC decreases patient survival significantly. This is mainly caused by a higher mortality within the first 30 postoperative days in these patients.
